SGH
MRNA icon

Sivik Global Healthcare’s Moderna MRNA Stock Holding History

Sivik Global Healthcare’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,000
Closed -$2.33M – 44
2022
Q4 		$2.33M Buy
+13,000
New +$2.13M 1.1% 37
2022
Q2 		– Sell
-10,000
Closed -$1.72M – 48
2022
Q1 		$1.72M Buy
+10,000
New +$1.68M 0.71% 48
2021
Q2 		– Sell
-15,000
Closed -$1.96M – 58
2021
Q1 		$1.96M Buy
+15,000
New +$2.17M 0.72% 42
2019
Q1 		– Sell
-25,000
Closed -$382K – 64
2018
Q4 		$382K Buy
+25,000
New +$411K 0.21% 48

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sivik Global Healthcare's MRNA Position: Q1 2023 in Review

Sivik Global Healthcare sold out of Moderna (MRNA) in Q1 2023, closing a stake of 13,000 shares — an estimated $2.33M sold.

Sivik Global Healthcare first reported a position in MRNA in Q4 2018 and held it in 4 quarters. The position peaked at $2.33M in Q4 2022. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Sivik Global Healthcare reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Sivik Global Healthcare sold 13,000 Moderna shares in Q1 2023, an estimated $2.33M.
  • Sivik Global Healthcare first reported a position in Moderna in Q4 2018 and held it in 4 quarters.
  • Sivik Global Healthcare's Moderna position peaked at $2.33M in Q4 2022.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Sivik Global Healthcare's 13F filing for Q1 2023, filed 8 May 2023.